Correlation Between Quoin Pharmaceuticals and Cyclacel Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Cyclacel Pharmaceuticals.

Diversification Opportunities for Quoin Pharmaceuticals and Cyclacel Pharmaceuticals

0.61

Correlation Coefficient

Quoin Pharmaceuticals  Cyclacel Pharmaceuticals

Poor diversification

The 3 months correlation between Quoin and Cyclacel is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Cyclacel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Cyclacel Pharmaceuticals

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Cyclacel Pharmaceuticals. In addition to that, Quoin Pharmaceuticals is 1.45 times more volatile than Cyclacel Pharmaceuticals. It trades about -0.08 of its total potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.03 per unit of volatility. If you would invest  41.00  in Cyclacel Pharmaceuticals on December 2, 2024 and sell it today you would lose (8.00) from holding Cyclacel Pharmaceuticals or give up 19.51% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Quoin Pharmaceuticals Ltd  vs.  Cyclacel Pharmaceuticals

Quoin Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Quoin Pharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Cyclacel Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cyclacel Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with Quoin Pharmaceuticals and Cyclacel Pharmaceuticals

The main advantage of trading using opposite Quoin Pharmaceuticals and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.

The idea behind Quoin Pharmaceuticals Ltd and Cyclacel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.